Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-054388

Chairman and CEO bought 1,500 shares at an average $1.02 ($1,530)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-10-07 Purchase +1,000 $1.03 $1,030 10,702,746 D
Niihara Yutaka Chairman and CEO 2020-10-08 Purchase +500 $1.00 $500 10,703,246 D
Open-market purchases · 1,500 sh · avg $1.02 · $1,530
Loading xslF345X03/doc4.xml…